From pipeline to neglected patients: overcoming challenges in drug discovery for NTDs
"From pipeline to neglected patients: overcoming challenges in drug discovery for NTDs" is a panel part of the annual ISNTD conference on drug discovery, development & diagnostics for neglected tropical diseases: ISNTD d3.
In this session, the speakers gave the following presentations and updates on ongoing research seeking to deliver new treatments against a range of neglected tropical diseases, before answering questions in a short discussion:
"Evaluating Care and Management of Individuals Impacted by chronic manifestations of NTDs", Dr Lorraine Pfavayi (Postdoctoral Research Associate, University of Edinburgh)
"Short-course combination treatment for experimental chronic Chagas disease", Dr Manu de Rycker (Head of Translational Parasitology and Portfolio Leader for Kinetoplastid Drug Discovery at the Drug Discovery Unit, University of Dundee)
"Identifying novel snake venom metalloproteinase toxin inhibitors", Dr Rachel Clare (Department of Tropical Disease Biology, Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine)
"Repurposing of Tuberculosis drug candidates for the treatment of Mycobacterium ulcerans disease", Dr Louisa Warryn (Swiss Tropical and Public Health Institute)
"Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities", Dr Exequiel Porta (Research Fellow in Chemistry, UCL School of Pharmacy, University College London)
This video was recorded on March 7th 2024 online, as part of the annual conference ISNTD d3.